Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics With Horizontal or Vertical Releasing Incisions

Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics (PAOO) With Horizontal or Vertical Releasing Incisions

The study aims to compare the effect of periodontal accelerated osteogenic orthodontics (PAOO) with horizontal or vertical releasing incisions on operation time, healing, adverse effects, and effectiveness of bone augmentation.

Methods: A total of 22 patients requiring PAOO surgery due to orthodontic treatment were enrolled in this trial, and randomly divided into test or control group, consisting of 11 subjects in each. The test group will receive PAOO with horizontal extending incisions on both sides of the flap; while the control group will receive PAOO with vertical releasing incisions; the two groups use the same surgical technic except for the incision design. Outcome measures include: operation time, postoperative scar, radiographic data (alveolar height and alveolar ridge thickness), gingival thickness, etc. Clinical evaluation will be performed at 1 week, 2 weeks, 3months, 6 months and 12 months after operation.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310000
        • Recruiting
        • 2nd Affiliated Hospital, School of Medicine, Zhejiang University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients aged between 18 and 40 years old, systemic healthy, undergoing or planning to undergo orthodontic treatment.
  2. Patients with a thin alveolar bone or with dehiscence and/or fenestration on the labial side of maxillary or mandibular front teeth area.
  3. Patients with expected tooth movement beyond the labial alveolar bone during orthodontic procedures.

Exclusion Criteria:

  1. Smoker.
  2. Pregnant or lactating.
  3. Untreated periodontitis.
  4. Presence of <2mm keratinized gingival width(KGW) or thin gingival phenotype (as defined by dental probe transparency.)
  5. History of orthodontic and/or orthognathic treatment.
  6. With systemic disease (diabetes, hypertension, heart disease, malignant tumor, severe mental illness, and other surgical contraindications.)
  7. Long-term medication (immunosuppressive drugs, bisphosphonates, etc.)
  8. Poor adherence to complete one-year follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: HEI
PAOO with horizontally extending incisions on both sides
An intrasulcular incision will be made on the labial side of the front teeth with a thin alveolar bone or dehiscence and/or fenestration. Then horizontally extending incisions will be added to each side of the Intrasulcular incision, extending one to two teeth beyond the defected area, before a full-thickness flap is lifted.
ACTIVE_COMPARATOR: VRI
PAOO with vertical releasing incisions on both sides
An intrasulcular incision will be made on the labial side of the front teeth with a thin alveolar bone or dehiscence and/or fenestration. Vertical releasing incisions will be made on each side of the intrasulcular incision before a full-thickness flap is lifted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgury time
Time Frame: 1 day
Timing will start when the first incision is about to be made, and end when the last suture is complete. The time in between will be recorded as surgury time.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
probing depth (PD)
Time Frame: 12 months
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
12 months
clinical attachment level (CAL)
Time Frame: 12 months
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
12 months
keratinized gingival width (KGW)
Time Frame: 12 months
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
12 months
gingival recession depth (GRD)
Time Frame: 12 months
It will be measured at baseline and 3 months, 6 months, and 12months after surgery.
12 months
gingival thickness (GT)
Time Frame: 12months
gingival phenotype as defined by dental probe transparency
12months
alveolar ridge height
Time Frame: 12 months
The height of the alveolar ridge, which is measured on CBCT from the most coronal point to the root apex.
12 months
alveolar ridge horizontal thickness
Time Frame: 12 months
measured on CBCT at the most coronal section, and 2mm, 4mm to the most coronal point, denoted as BW0, BW2, and BW4
12 months
facial swelling
Time Frame: 2 weeks
recorded "0" for no facial swelling; "1" for mild facial swelling; "2" for severe facial swelling.
2 weeks
pain level
Time Frame: 2 weeks
measured with VAS score
2 weeks
mucosal color
Time Frame: 2 weeks
recorded "0" for no redness along the incision; "1" for slight redness; "2" for obvious redness.
2 weeks
edema
Time Frame: 2 weeks
recorded "0" for no edema around the surgery area; "1" for mild edema; "2" for severe edema.
2 weeks
membrane exposure
Time Frame: 2 weeks
recorded "0" if there is no membrane exposure, and "1" if there is any membrane exposure.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2022

Primary Completion (ANTICIPATED)

June 30, 2024

Study Completion (ANTICIPATED)

June 30, 2025

Study Registration Dates

First Submitted

June 13, 2022

First Submitted That Met QC Criteria

June 28, 2022

First Posted (ACTUAL)

July 1, 2022

Study Record Updates

Last Update Posted (ESTIMATE)

February 14, 2023

Last Update Submitted That Met QC Criteria

February 12, 2023

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malocclusion

Clinical Trials on horizontally extending incision

3
Subscribe